| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Nutlin-3a (-) | GDSC1000 | pan-cancer | AAC | -0.0078 | 0.8 |
| mRNA | ABT-888 | CTRPv2 | pan-cancer | AAC | -0.0078 | 0.8 |
| mRNA | BRD-K48477130 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | lenalidomide | FIMM | pan-cancer | AAC | 0.046 | 0.8 |
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | 0.0073 | 0.8 |
| mRNA | Vandetanib | FIMM | pan-cancer | AAC | 0.047 | 0.8 |
| mRNA | paclitaxel | CTRPv2 | pan-cancer | AAC | -0.0065 | 0.8 |
| mRNA | SB 216763 | GDSC1000 | pan-cancer | AAC | 0.0079 | 0.9 |
| mRNA | YK 4-279 | GDSC1000 | pan-cancer | AAC | -0.0074 | 0.9 |
| mRNA | BRD-K94991378 | CTRPv2 | pan-cancer | AAC | 0.0074 | 0.9 |